Bellevue Asset Management’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-129
| Closed | -$1.02K | – | 475 |
|
|
2025
Q1 | $1.02K | Hold |
129
| – | – | ﹤0.01% | 473 |
|
|
2024
Q4 | $1.63K | Hold |
129
| – | – | ﹤0.01% | 459 |
|
|
2024
Q3 | $1.8K | Buy |
129
+36
| +39% | +$501 | ﹤0.01% | 424 |
|
|
2024
Q2 | $1.28K | Hold |
93
| – | – | ﹤0.01% | 449 |
|
|
2024
Q1 | $1.54K | Hold |
93
| – | – | ﹤0.01% | 436 |
|
|
2023
Q4 | $1.36K | Hold |
93
| – | – | ﹤0.01% | 434 |
|
|
2023
Q3 | $1.14K | Hold |
93
| – | – | ﹤0.01% | 443 |
|
|
2023
Q2 | $1.11K | Buy |
+93
| New | +$1.11K | ﹤0.01% | 472 |
|
|
2023
Q1 | – | Sell |
-62
| Closed | -$1.31K | – | 490 |
|
|
2022
Q4 | $1.31K | Hold |
62
| – | – | ﹤0.01% | 457 |
|
|
2022
Q3 | $1K | Buy |
+62
| New | +$1K | ﹤0.01% | 464 |
|